Taiwan’s President Lai Ching-te’s administration has significantly escalated its drug policy by reclassifying etomidate as a Category 1 Narcotic. This re-categorization carries severe consequences, potentially including the death penalty for individuals involved in the manufacture, transportation, or sale of the substance. The move signals a markedly harder line on drug offenses under the new administration. Previously, etomidate was subject to less stringent penalties. Authorities have not publicly detailed the specific reasoning behind the reclassification, but it is understood to be part of a broader effort to combat illicit drug activity. Legal experts suggest the change reflects a desire to deter trafficking and production. The policy is expected to draw scrutiny from human rights organizations concerned about capital punishment.